Slide 1: Consolidated Financial Statements of fiscal year 2017 and outlook
JENOPTIK AG Consolidated Financial Statements of fiscal year 2017 and outlook Dr. Stefan Traeger, President & CEO © Copyright Jenoptik. All rights reserved. Hans-Dieter Schumacher, CFO I March 22, 2018
Slide 2: Agenda
1 Development of the Jenoptik Group 2 Performance of the segments 3 Strategy and outlook 4 Appendix 22.3.2018 Financial Statements 2017 © 2018 JENOPTIK AG, All rights reserved. 2
Slide 3: Highlights in 2017
Highlights in 2017 Acquisition of ESSA Technology, UK Grand opening of our new technology campus in Detroit, Michigan Acquisition of Five Lakes Automation, US Establishment of an application center Strong growth and in the Silicon Valley margin expansion Revenue of 747.9 million euros +9
Slide 4: 2017 – revenue showed stronger growth than expected
2017 – revenue showed stronger growth than expected Revenue in million euros 800 +9.2% 747.9 700 684.8 600 500 400 300 +15.0% 221.1 200 192.2 184.7 178.4 158.2 168.7 165.7 163.7 100 0 Q1/16 Q2/16 Q3/16 Q4/16 2016 Q1/17 Q2/17 Q3/17 Q4/17 2017 Growth in particular in the Optics & Life Science as wel
Slide 5: Strong growth in strategic target regions – Foreign revenue > 70 percent
Strong growth in strategic target regions – Foreign revenue > 70 percent EUROPE +2.5% GERMANY 1.7% 434.9 424.3 226.5 222.6 AMERICAS +28.5% ASIA / 173.6 PACIFIC 135.2 AFRICA / +11.1% MIDDLE EAST +12.0% 111.3 100.2 25.1 28.1 22.3.2018 Financial Statements 2017 © 2018 JENOPTIK AG, All rights reserved.
Slide 6: Automotive remains biggest target market
Automotive remains biggest target market Revenue by target market (prior year figures in brackets) Other Medical technology Automotive / Mechanical 5% 6% (7%) engineering Semiconductor (6%) Automotive / mechanical engineering: 30% equipment 17% (31%) strong demand for laser machines industry (13%)
Slide 7: 2017 – significant improvement of operating results
2017 – significant improvement of operating results EBITDA* in million euros 150 120 +12.8% 106.7 EBITDA* showed stronger increase 94.7 than revenue 90 Continuous improvement in the course 60 +14.7% of the year 33.8 24.3 24.5 29.3 25.0 30.3 Optics & Life Science with substantially 30 16.6 17.7
Slide 8: Successful business development is also reflected in marked EPS improvement
Successful business development is also reflected in marked EPS improvement Revenue 747.9 684.8 Gross margin improved, in particular due to positive development in the Optics & Life Gross margin 35.3% 34.7% Science segment Functional costs 179.2 173.5 R+D as well as selling expenses exceeded pri
Slide 9: 2017 – solid order position and project pipeline create good basis for further growth
2017 – solid order position and project pipeline create good basis for further growth Order intake in million euros Order backlog in million euros Frame contracts in million euros 1000 600 250 +9.4% 500 +11.9% 800 200 802.9 733.8 400 453.5 600 405.2 150 45.6% 160.9 300 400 100 200 87.6 200 50 100
Slide 10: Free cash flow remained at a good level in spite of higher investments
Free cash flow remained at a good level in spite of higher investments and increase in inventories In million euros 2017 2016 Operating profit before 107.5 95.6 Working capital rose to 214,8 million adjusting working capital euros (31.12.16: 209.9m euros), in particular due to order-related higher
Slide 11: Net debt substantially reduced, Jenoptik remained net debt free in 2017
Over the past years, net debt was substantially reduced, Jenoptik has remained net debt free in 2017 Net debt in million euros 300 ~260 Jenoptik Group remained free of 250 net debt in spite of ~60 200 higher investments, payment of an increased 150 106 dividend of 14.3 million euros 104 100 20
Slide 12: Number of employees abroad continued to rise
Number of employees abroad continued to rise GERMANY JENA +25 +3 2,878 (2,853) 1,228 (1,225) AMERICAS EUROPE ASIA / PACIFIC +61 346 (285) +31 258 (227) +49 3,076 (3,027) 22.3.2018 Financial Statements 2017 © 2018 JENOPTIK AG, All rights reserved. 12
Slide 13: Performance of the segments
1 Development of the Jenoptik Group 2 Performance of the segments 3 Strategy and outlook 4 Appendix 22.3.2018 Financial Statements 2017 © 2018 JENOPTIK AG, All rights reserved. 13
Slide 14: Optics & Life Science segment: new record in revenue and earnings
Optics & Life Science segment: new record in revenue and earnings Revenue (in million euros) EBIT (in million euros) Order intake (in million euros) 300 60 300 +17.1% +24.9% 295.5 250 50 51.1% 250 259.4 50.0 200 221.5 40 236.6 200 150 30 33.4 150 100 20 100 50 10 50 0 0 0 2016 2017 2016 2017 2016 20
Slide 15: Mobility segment: project-related one-off expenses affected result
Mobility segment: project-related one-off expenses affected result; positive development in the second half-year Revenue (in million euros) EBIT (in million euros) Order intake (in million euros) 300 +9.0% 30 350 +13.6% 250 270.1 25 24.2% 300 247.7 303.7 24.4 250 200 20 267.4 18.5 200 150 15 150 10
Slide 16: Defense & Civil Systems segment: development as expected
Defense & Civil Systems segment: development as expected, course of business affected by major projects Revenue (in million euros) EBIT (in million euros) Order intake (in million euros) 250 +0.5% 25 240 11.0% +0.3% 231.6 200 218.3 219.3 20 200 206.2 19.1 19.2 150 15 160 120 100 10 80 50 5 40 0 0 0
Slide 17: Strategy and outlook
Preliminary results 2017 1 Development of the Jenoptik Group 2 Performance of the segments 3 Strategy and outlook 4 Appendix 22.3.2018 Financial Statements 2017 © 2018 JENOPTIK AG, All rights reserved. 17
Slide 18: Transforming Jenoptik into a focused technology group
Transforming Jenoptik into a focused technology group Strategy 2022: three building blocks for growth and margin expansion We leverage our core We step-up our R+D work We build a truly global competencies enterprise in Optics & Photonics 22.3.2018 Financial Statements 2017 © 2018 JENOPTIK AG, All ri
Slide 19: Our priorities for 2018
Our priorities for 2018 We launch a new brand for our mechatronic business We establish a new business structure We reorganize our business in Asia 22.3.2018 Financial Statements 2017 © 2018 JENOPTIK AG, All rights reserved. 19
Slide 20: Our 2018 guidance
Our 2018 guidance Group financial guidance for 2018* We expect revenue to be in a range between 790 and 810 million euros. We anticipate an EBITDA margin between 14.5 and 15.0 percent. We expect an EBIT margin between 10.5 and 11.0 percent. 2018 2018 *This presupposes that political and econom
Slide 21: Our mid-term guidance
Our mid-term guidance Group 5-year targets: accelerated growth and margin expansion Revenue growth We expect mid- to high-single digit revenue growth (CAGR) for the Group. Margin increase By 2022, we expect to achieve an EBITDA margin for the Group of around 16 percent. 22.3.2018 Financial Statement
Slide 22: Appendix
Preliminary results 2017 1 Development of the Jenoptik Group 2 Performance of the segments 3 Strategy and outlook 4 Appendix 22.3.2018 Financial Statements 2017 © 2018 JENOPTIK AG, All rights reserved. 22
Slide 23: Dates and contact
Dates and contact March 22, 2018 Financial Statements 2018, conference call March 23, 2018 Analysts‘ conference and Roadshow, Frankfurt/Main April 9-10, 2018 Roadshow Scandinavia April 19, 2018 Conference Bankhaus Lampe, Baden-Baden April 24, 2018 Roadshow Paris May 9, 2018 Results of the 1st quarte
Slide 24: Disclaimer
Disclaimer This presentation can contain forward-looking statements that are based on current expectations and certain assumptions of the management of the Jenoptik Group. A variety of known and unknown risks, uncertainties and other factors can cause the actual results, the financial situation, the